Filing Flows › Nuo Therapeutics (AURX) › Who owns the stock
Who owns Nuo Therapeutics (AURX) stock
1 funds reported Nuo Therapeutics (AURX) shares in their latest 13F filings, worth $4K in all. The largest holder is Ancora Advisors LLC ($4K). Last quarter 0 funds added to their stakes and 0 cut them.
Largest holders (13F)
| Fund | Shares | Value | Change | Quarter |
|---|---|---|---|---|
| Ancora Advisors LLC | 4,700 | $4K | unchanged | 2026-06-30 |
Nuo Therapeutics' latest quarter
Nuo Therapeutics, Q2 2026: revenue $1.8M (+153% year over year), operating margin -9.4%, net loss $278K, operating cash flow −$236K. The chart follows the revenue to costs, profit and cash.
Questions
Who owns the most AURX stock?
By the latest 13F filings: Ancora Advisors LLC ($4K).
What is the short interest in AURX?
87 shares were sold short at the 2026-10-15 settlement, -84.21% of the float.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.